News
1don MSN
New guidelines, developed and led by experts at the University of Nottingham, will help clinicians to better treat the ...
1d
Medpage Today on MSNIBD Biomarkers: Established Tests Are Helpful but Clinicians Want MoreTwo biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease ...
Two new indications of Tremfya (guselkumab) approved for the treatment of Inflammatory Bowel Disease
Tremfya is the first and only fully-human, dual-acting IL-23p19 subunit inhibitor approved in both ulcerative colitis and ...
It’s taking too long for people with Crohn’s and colitis to be diagnosed, but the sooner you start that process and ask for ...
Phase 1 data for Spyre Therapeutics, Inc.'s SPY002 & SPY072 show promise in autoimmune treatments. Advancing to Phase 2 ...
The former TOWIE star was diagnosed with ulcerative colitis after ignoring symptoms for almost a decade - an expert has now ...
5d
News-Medical.Net on MSNUnderstanding the interconnected roles of microbial, metabolic, and immune biomarkers in IBDInflammatory Bowel Disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is a chronic inflammatory ...
Patients with ulcerative colitis have a higher risk for cancer than the general population, with variations in cancer incidence more pronounced with age than with treatment status.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results